Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.

Diğer sürümleri göster (1)

Whole exome sequencing was performed in a patient with myelodysplastic syndrome before and after progression to acute myeloid leukaemia. Mutations in several genes, including SETBP1, were identified following leukaemic transformation. Screening of 328 patients with myeloid disorders revealed SETBP1...

Detaylı Bibliyografya
Asıl Yazarlar:	Fernandez-Mercado, M, Pellagatti, A, Di Genua, C, Larrayoz, M, Winkelmann, N, Aranaz, P, Burns, A, Schuh, A, Calasanz, M, Cross, N, Boultwood, J
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2013

Benzer Materyaller

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
Yazar:: Fernandez-Mercado, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia.
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Yazar:: Fernandez-Mercado, M, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
Yazar:: Piazza, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia Abrogate an Ubiquitination Site and Dysregulate SETBP1 Protein Levels
Yazar:: Gambacorti-Passerini, C, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.
Yazar:: Piazza, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics
Yazar:: Fernandez-Mercado, M, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

SF3B1 mutant myelodysplastic syndrome: Recent advances
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
Yazar:: Boultwood, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Gene expression profiling in the myelodysplastic syndromes.
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Cytogenetic profile in patients with primary myelodysplastic syndrome
Yazar:: S V Gritsaev, ve diğerleri
Baskı/Yayın Bilgisi: (2013-07-01)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
Yazar:: Fernandez-Mercado, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Trisomy 14 as the only cytogenetic abnormality in myelodysplastic syndrome
Yazar:: M. N. Pautova, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
Yazar:: Boultwood, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Prenatal diagnosis and molecular cytogenetic characterization of an inherited microdeletion of 18q12.3 encompassing SETBP1
Yazar:: Yaqing Zhou, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics.
Yazar:: Marta Fernandez-Mercado, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome
Yazar:: M A Pimenova, ve diğerleri
Baskı/Yayın Bilgisi: (2013-07-01)

Structural rearrangements as a recurrent pathogenic mechanism for SETBP1 haploinsufficiency
Yazar:: V. Alesi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Cytogenetic clonal evolution In myelodysplastic syndrome
Yazar:: Aw, Eunice Ching-Yi
Baskı/Yayın Bilgisi: (2018)

RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
Yazar:: Julie Schanz, ve diğerleri
Baskı/Yayın Bilgisi: (2015-04-01)

Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
Yazar:: Mohammad Faizan Zahid, ve diğerleri
Baskı/Yayın Bilgisi: (2016-12-01)

Identification of a novel de novo mutation of SETBP1 and new findings of SETBP1 in tumorgenesis
Yazar:: Hongdan Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
Yazar:: Armstrong, R, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes
Yazar:: Marta Fernandez-Mercado, ve diğerleri
Baskı/Yayın Bilgisi: (2013-12-01)

Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.
Yazar:: Li-Hong Shou, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Cytogenetic study of Brazilian patients with myelodysplastic syndrome (MDS)
Yazar:: Tamara Borgonovo, ve diğerleri
Baskı/Yayın Bilgisi: (2005-12-01)

CLINICAL AND CYTOGENETIC PROFILE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
Yazar:: Muneshwar Kumar, ve diğerleri
Baskı/Yayın Bilgisi: (2019-06-01)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
Yazar:: Boultwood, J, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Yazar:: Bernard, E, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Features of cytogenetic diagnosis of simultaneous chronic lymphocytic leukemia and myelodysplastic syndrome: clinical case report
Yazar:: M. A. Kislitsyna, ve diğerleri
Baskı/Yayın Bilgisi: (2019-10-01)

Molecular Cytogenetics Of Myelodysplastic Syndrome – Hospital Based Study
Yazar:: Isa, Asmida
Baskı/Yayın Bilgisi: (2014)

Cytogenetic features in primary myelodysplastic syndrome Egyptian patients
Yazar:: Yasser Elnahass, ve diğerleri
Baskı/Yayın Bilgisi: (2018-03-01)

Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?
Yazar:: Sílvia Saumell, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

The Role of SETBP1 in Gastric Cancer: Friend or Foe
Yazar:: Fujin Fang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

Neutrophil PRV-1 gene expression in myeloproliferative, myelodysplastic and reactive blood disorders
Yazar:: Zhang, J, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Association of loss of heterozygosity with cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome
Yazar:: R.F. Pinheiro, ve diğerleri
Baskı/Yayın Bilgisi: (2008-07-01)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

IMPACT PROGNOSIS OF CYTOGENETIC ALTERATIONS IN BRAZILIAN CHILDHOOD MYELODYSPLASTIC NEOPLASM
Yazar:: Viviane Lovatel, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)